acute%20coronary%20syndromes%20w_out%20persistent%20st-segment%20elevation
ACUTE CORONARY SYNDROMES W/OUT PERSISTENT ST-SEGMENT ELEVATION
Acute coronary syndromes refer to any constellation of clinical symptoms compatible with acute myocardial ischemia which may be life-threatening.
It encompasses unstable angina, non-ST-segment elevation myocardial infarction (NSTEMI) and ST-segment elevation myocardial infarction (STEMI).
Unstable angina is the ischemic discomfort that presents without persistent ST-segment elevation on ECG and without the presence of cardiac markers in the blood.
Non-ST-segment elevation myocardial infarction is diagnosed if cardiac markers are positive with ST-segment depression or with nonspecific or normal ECGs.
The patient typically presents with ischemic-type chest pain that is severe and prolonged and may occur at rest or may be caused by less exertion than previous episodes.
Drug Information

Indication: 60 mg: Co-administered w/ acetylsalicylic acid (ASA) for prevention of atherothrombotic events in adult patien...

Indication: Symptomatic treatment of chronic stable angina pectoris in CAD adults w/ normal sinus rhythm & heart rate&...

Indication: Substitution treatment of essential HTN &/or stable CAD in patients already controlled w/ perindopril &...

Indication: Add-on therapy for symptomatic treatment in adults w/ stable angina pectoris who are inadequately controlled b...

Azoren
amlodipine besylate + olmesartan medoxomil

Indication: Essential HTN in patient whose BP is inadequately controlled on olmesartan medoxomil or amlodipine monotherapy...

Indication: HTN.

Indication: HTN & chronic stable angina.

Indication: CHD: Chronic stable angina pectoris; HTN.

Indication: In combination w/ heparin for patients w/ unstable angina or non-Q-wave MI to prevent cardiac ischemic events ...

1  /  16
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Cardiology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Jairia Dela Cruz, 5 days ago
Use of aspirin in the primary prevention of cardiovascular disease (CVD) in patients with no prior CVD history yields protection against the risks of acute myocardial infarction (AMI) and ischaemic stroke, but at the expense of an increase of similar magnitude in the incidence of major bleeding, according to the results of a recent meta-analysis presented at the European Society of Cardiology (ESC) Congress 2019 in Paris, France.
Stephen Padilla, 16 Jul 2019
Symptomatic pericardial effusions are most commonly caused by cancer and iatrogenic complications, results of a Singapore study in an academic medical centre have found. Nonetheless, success rate is high and complications are relatively low in pericardiocentesis.
Tristan Manalac, 26 Jun 2019
New cases of pericardial effusion (PE) and increases in severity of tricuspid regurgitation (TR) occur relatively rarely soon after cardiac implantable electronic device (CIED) implantation, according to a new study.
Dr Margaret Shi, 4 days ago

A comprehensive model of care delivered by nonphysician health workers (NPHWs), involving primary care physicians and families that was informed by local context, substantially improved blood pressure (BP) control and cardiovascular disease (CVD) risk, according to results of the HOPE 4 trial reported at the European Society of Cardiology (ESC) Congress 2019 and World Congress of Cardiology (WCC) 2019.